These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 26819057

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy of interferon-alpha in essential thrombocythemia during pregnancy.
    Yoshida Y, Katsurada T, Nakabou Y, Kawabata H.
    Ann Hematol; 2017 May; 96(5):877-878. PubMed ID: 28194492
    [No Abstract] [Full Text] [Related]

  • 3. A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.
    Mascarenhas J, Kosiorek H, Prchal J, Yacoub A, Berenzon D, Baer MR, Ritchie E, Silver RT, Kessler C, Winton E, Finazzi MC, Rambaldi A, Vannucchi AM, Leibowitz D, Rondelli D, Arcasoy MO, Catchatourian R, Vadakara J, Rosti V, Hexner E, Kremyanskaya M, Sandy L, Tripodi J, Najfeld V, Farnoud N, Salama ME, Weinberg RS, Rampal R, Goldberg JD, Mesa R, Dueck AC, Hoffman R.
    Leukemia; 2019 Dec; 33(12):2974-2978. PubMed ID: 31363161
    [No Abstract] [Full Text] [Related]

  • 4. Distinct efficacy of pegylated-interferon α2a and α2b during treatment of essential thrombocythemia.
    Noel N, Michot JM, Besson C, Goujard C, Lambotte O.
    Int J Hematol; 2013 Mar; 97(3):438-9. PubMed ID: 23400413
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review.
    Sakai K, Ueda A, Hasegawa M, Ueda Y.
    Int J Hematol; 2018 Aug; 108(2):203-207. PubMed ID: 29290077
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Multiple gestation in an essential thrombocythemia patient treated with interferon-alpha.
    Nevruz O, Goktolga U, Avcu F, Ozsari L, Ural AU.
    Acta Obstet Gynecol Scand; 2007 Aug; 86(7):893-5. PubMed ID: 17611839
    [No Abstract] [Full Text] [Related]

  • 9. Interferon therapy for pregnant patients with essential thrombocythemia in Japan.
    Edahiro Y, Yasuda H, Gotoh A, Morishita S, Suzuki T, Takeda J, Ando J, Tsutsui M, Itakura A, Komatsu N.
    Int J Hematol; 2021 Jan; 113(1):106-111. PubMed ID: 32965639
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Essential thrombocythaemia treated with recombinant interferon: 'real world' United Kingdom referral centre experience.
    Desterro J, McLornan DP, Curto Garcia N, O'Sullivan J, Alimam S, Keohane C, Woodley C, Francis Y, Kordasti S, Radia DH, Harrison CN.
    Br J Haematol; 2019 Aug; 186(4):561-564. PubMed ID: 31090926
    [Abstract] [Full Text] [Related]

  • 12. Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.
    Langer C, Lengfelder E, Thiele J, Kvasnicka HM, Pahl HL, Beneke H, Schauer S, Gisslinger H, Griesshammer M.
    Haematologica; 2005 Oct; 90(10):1333-8. PubMed ID: 16219569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alpha 2b-interferon therapy and pregnancy--report of a case of essential thrombocythemia.
    Pardini S, Dore F, Murineddu M, Bontigli S, Longinotti M, Grigliotti B, Spano B.
    Am J Hematol; 1993 May; 43(1):78-9. PubMed ID: 8317474
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Successful treatment of essential thrombocythemia with alpha interferon during pregnancy.
    Thornley S, Manoharan A.
    Eur J Haematol; 1994 Jan; 52(1):63-4. PubMed ID: 8299772
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Pegylated intereferon hematological safety in comparison with standard].
    Fazylov VKh, Manapova ÉR, Tkacheva SV, Sozinova IuM.
    Eksp Klin Gastroenterol; 2012 Jan; (6):96-9. PubMed ID: 23402198
    [Abstract] [Full Text] [Related]

  • 19. Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome.
    Choi C, Moller D, Tan J, Dou C, Peterson EA, Medvedev N, Dutz JP, Carruthers MN, Chen LYC.
    Br J Haematol; 2020 Mar; 188(5):e68-e72. PubMed ID: 31721154
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.